Navigation Links
URAC Invites Public Input in Response to Revisions to Health Plan and Health Network Accreditation Programs
Date:4/1/2008

New standards support principles of Consumer-Purchaser Disclosure Project, include review of physician quality measurement programs

WASHINGTON, April 1, 2008 /PRNewswire-USNewswire/ -- Today URAC called for public comment on revisions to its Health Plan and Health Network accreditation program standards. URAC is seeking input from all interested parties, including purchasers, policy makers, consumers, health care management organizations and health plans. The deadline for public comment is May 19, 2008.

(Logo: ttp://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO )

Among the revisions are specific standards applicable to those organizations that implement and publicly report on their physician quality measurement programs. The new standards are consistent with the general principles proposed by the Consumer-Purchaser Disclosure Project in its Patient Charter for Physician Performance, Measurement and Tiering Programs.

"These revisions align with URAC's strategic focus on enhancing consumer empowerment and protection through accreditation," said Alan P. Spielman, URAC's president and CEO. "The standards are a blueprint for organizations to develop systems that give consumers the information they need to make choices based on provider quality."

The Patient Charter is supported by leading consumer, labor and employer groups and aligns with URAC's work over the past four years to enhance consumer education, safety and empowerment through its accreditation programs.

"The Health Network and Health Plan Standards have completed the first round of updates by the Standards Committee. Many enhancements and clarifications have been proposed. This includes the introduction of new standards to address Health Care Performance reporting," said Douglas Metz, chairman of the Health Standards Committee and chief health services officer for American Specialty Health.

Performance reporting on quality is an important c
'/>"/>

SOURCE URAC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HHS Deputy Secretary Invites Toledo Community to Apply for an Innovative Electronic Health Record Demonstration Project
2. URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards
3. USDA invites industry to partner with MyPyramid
4. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
5. Malaria Community Applauds Clintons $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments
6. American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Sector Focus Conference
8. Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast
9. Par Invites Public to Listen to Webcast of its September 28 Analysts Meeting
10. Help Raise Awareness of Obesity - Annual Walk From Obesity Invites Participants to Join a Walk in Their Local Area
11. Dole Invites Consumers to Show Their Wild Side!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...J., Dec. 2 Cantel Medica... to discuss the Company,s results for its first qu...t 11:00 AM ET. Participating in the call will be ...esident; Craig A. Sheldon, Senior Vice President a...orporation. Minntech is a Cantel subsidiary. The f...
(Date:12/2/2008)... Ingenious Med (IM) welcomes new CE...der in inpatient practice,management solutions, w...are,software, revenue management, medical servic... nine-year CEO, Dr. Steven Liu, is confident Willi...opment in all sectors, as he steps into,the role....
(Date:12/2/2008)...moms who took it in first 3 months more likely to ...2 (HealthDay News) -- Infants whose mothers take f... an increased risk for respiratory illness, accord...ed to reduce the risk of birth defects, and many c... The researchers examined data on more than 32,000...
(Date:12/2/2008)... researchers at The University of Nottingham has i...cancer. , The research, published in the journal..., USA and funded by a 72,000 grant from the Britis...essor gene, LIMD1, is responsible for protecting t...y for possible new treatments and early screening ...
Breaking Medicine News(10 mins):Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008 2Health News:Ingenious Med Hires New CEO to Maintain and Further Expand Company Development 2Health News:Folate in Early Pregnancy May Boost Wheezing in Baby 2Health News:Gene which protects against lung cancer identified 2
...of developing pancreatic cancer increases by 90% w... // Pancreatic cancer risk was 70% higher in peopl...times a day when compared with those who added no ...r intake been already considered as a risk factor,...
...p of hospital services in east Lancashire by a cou...ers. // East Lancashire Hospitals NHS Trust has ... of Burnley's A&E department that will now not be ...the overview and scrutiny by the council’s committ...
...nother anti-polio drive Sunday even as new polio c... detected. During the drive, pulse polio drops wo...of up to five years of age, according to health of...case of polio was confirmed by the National Polio ...
...al Of American Medical Association announced that ... might not be completely bad. In fact a theory by ...as brought the association of heart attach and hig...r. Gheorghiade through his research found that dur...
Other Medicine News:Health News:Fury over Backing of Health Shake-up 2
(Date:11/25/2008)...nst expanding statin use broadly in wake of AHA-pr...25 JUPITER, a clinical trial sugge...sk of healthy patients with elevated CRP, should n...cording to a national poll directed at health prof...e online poll conducted by medical news site MedPa...
(Date:11/25/2008)... Poniard,Pharmaceutical...pany focused on,innovative oncology therapies, an... alternatives for its preclinical research program...urces on the clinical development of picoplatin,...tial commercialization of,picoplatin in the treat...
(Date:11/25/2008)...ial to Assess Survival of Patients Receiving Litx ... Hepatocellular Carcinoma , , BELLEVUE, Was...y, Inc. (LSO) today announced the completion of en...ht Infusion Therapy(TM) (Litx(TM)) as a treatment ...lso known as hepatoma or primary liver cancer. , ...
(Date:11/24/2008)...ov. 24 Takeda Pharmaceutical Compa... Global Research & Development Center, Inc., U...ommittee of the U.S. Food and Drug Administration ... for the treatment of hyperuricemia in patients wi...val, with one panel member abstaining. The vote fo...
Breaking Medicine Technology:Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Biophysical Society names 2009 award recipients 4751 1Biophysical Society names 2009 award recipients 4751 2Leaders in Pathology Meet in San Diego 3A Sept 25 28 2008 26107 1Leaders in Pathology Meet in San Diego 3A Sept 25 28 2008 26107 2HRSA Announces 2439 Million in Grants to Expand Improve Health Center Services 26105 1HRSA Announces 2439 Million in Grants to Expand Improve Health Center Services 26105 2Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year 7513 1Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year 7513 2
...pr 10, 2007 - Valeant,Pharmaceuticals Internationa...ase 2 data for retigabine, a first-in-class,neuron...ng,independent, scientific journal. The authors co...onstrated reduction in monthly,seizure rates in th... RESTORE2) are currently underway to further inves...
...es Insulin-Free, WASHINGTON, April 10, 2007 /PRNew...lt stem cell therapy, the Journal of the,American ...in which,14 of 15 Juvenile Diabetes patients demon...adult stem cell treatment. According,to U.S. Rep. ... in,that it,s the first attempt at using stem cell...
Other Medicine Technology:Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 2Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 3Newest Adult Stem Therapy Treats Diabetes 2
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump.
...ARE TVT is a minimally invasive, highly effective ...rinary incontinence. GYNECARE TVT is positioned cl...when needed, TVT provides tension-free support of ... takes approximately 20 to 30 minutes, with minima...
SUR-FIT® AutoLock® Urostomy Pouch with Accuseal® Tap
New Image Urostomy Pouch, Ultra-Clear
Medicine Products: